BACKGROUND: Zika Virus (ZIKV), member of Flaviviridae family and Flavivirus genus, has recently emerged as international public health emergency after its association with neonatal microcephaly cases. Clinical diagnosis hindrance involves symptom similarities produced by other arbovirus infections, therefore laboratory confirmation is of paramount importance. DISCUSSION: The most reliable test available is based on ZIKV RNA detection from body fluid samples. However, short viremia window periods and asymptomatic infections diminish the success rate for RT-PCR positivity. Beyond molecular detection, all serology tests in areas where other Flavivirus circulates proved to be a difficult task due to the broad range of cross-reactivity, especially with dengue pre-exposed individuals. CONCLUSION: Altogether, lack of serological diagnostic tools brings limitations to any retrospective evaluation. Those studies are central in the context of congenital infection that could occur asymptomatically and mask prevalence and risk rates.
BACKGROUND: Zika Virus (ZIKV), member of Flaviviridae family and Flavivirus genus, has recently emerged as international public health emergency after its association with neonatal microcephaly cases. Clinical diagnosis hindrance involves symptom similarities produced by other arbovirus infections, therefore laboratory confirmation is of paramount importance. DISCUSSION: The most reliable test available is based on ZIKV RNA detection from body fluid samples. However, short viremia window periods and asymptomatic infections diminish the success rate for RT-PCR positivity. Beyond molecular detection, all serology tests in areas where other Flavivirus circulates proved to be a difficult task due to the broad range of cross-reactivity, especially with dengue pre-exposed individuals. CONCLUSION: Altogether, lack of serological diagnostic tools brings limitations to any retrospective evaluation. Those studies are central in the context of congenital infection that could occur asymptomatically and mask prevalence and risk rates.
Authors: Susannah Colt; Maria N Garcia-Casal; Juan Pablo Peña-Rosas; Julia L Finkelstein; Pura Rayco-Solon; Zita C Weise Prinzo; Saurabh Mehta Journal: PLoS Negl Trop Dis Date: 2017-04-10
Authors: Robert S Lanciotti; Olga L Kosoy; Janeen J Laven; Jason O Velez; Amy J Lambert; Alison J Johnson; Stephanie M Stanfield; Mark R Duffy Journal: Emerg Infect Dis Date: 2008-08 Impact factor: 6.883
Authors: Nischay Mishra; Adrian Caciula; Adam Price; Riddhi Thakkar; James Ng; Lokendra V Chauhan; Komal Jain; Xiaoyu Che; Diego A Espinosa; Magelda Montoya Cruz; Angel Balmaseda; Eric H Sullivan; Jigar J Patel; Richard G Jarman; Jennifer L Rakeman; Christina T Egan; Chantal B E M Reusken; Marion P G Koopmans; Eva Harris; Rafal Tokarz; Thomas Briese; W Ian Lipkin Journal: mBio Date: 2018-03-06 Impact factor: 7.867
Authors: Erum Khan; Dhani Prakoso; Kehkashan Imtiaz; Faisal Malik; Joveria Q Farooqi; Maureen T Long; Kelli L Barr Journal: Front Public Health Date: 2020-06-17
Authors: Lara Ferrero Gomez; Susana Campino; Taane G Clark; Daniel Ward; Ana Rita Gomes; Kevin K A Tetteh; Nuno Sepúlveda Journal: Sci Rep Date: 2022-07-09 Impact factor: 4.996